Y-mAbs Therapeutics (YMAB) Stock Chart & Stock Price History → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free YMAB Stock Alerts $14.71 -0.13 (-0.88%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Y-mAbs Therapeutics Stock Price Performance5 Day Performance-2.78%1 Month Performance-6.31%3 Month Performance+30.52%6 Month Performance+172.91%Year-To-Date Performance+115.69%1 Year Performance+158.52% Receive YMAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. YMAB Stock Chart for Friday, April, 26, 2024 YMAB Chart by TradingView Y-mAbs Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$14.84$14.71-0.88%$15.13$14.36189,746 shs$644.00 million04/25/2024$15.29$14.84-2.94%$15.44$14.28365,385 shs$649.65 million04/24/2024$15.34$15.29-0.33%$15.46$15.02158,213 shs$669.40 million04/23/2024$15.16$15.34+1.19%$16.39$14.90513,319 shs$671.59 million04/22/2024$15.13$15.16+0.20%$15.86$14.96472,659 shs$663.71 million04/19/2024$15.00$15.13+0.87%$15.41$14.71467,186 shs$662.39 million Get the Latest News and Ratings for YMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$15.11$15.00-0.73%$15.46$14.82410,152 shs$656.70 million04/17/2024$15.14$15.11-0.20%$15.41$14.89450,529 shs$661.52 million04/16/2024$14.91$15.14+1.54%$15.69$14.50442,474 shs$662.83 million04/15/2024$14.37$14.91+3.76%$14.95$14.21297,629 shs$652.76 million04/12/2024$14.63$14.37-1.78%$14.68$14.06237,905 shs$629.12 million04/11/2024$13.79$14.63+6.09%$14.82$13.91246,933 shs$640.46 million04/10/2024$14.07$13.79-1.99%$14.00$13.34375,827 shs$603.73 million04/09/2024$14.45$14.07-2.63%$14.57$13.85186,297 shs$615.99 million04/08/2024$14.46$14.45-0.07%$14.87$14.02168,443 shs$632.62 million04/05/2024$14.56$14.46-0.69%$15.08$14.34436,698 shs$633.06 million04/04/2024$14.42$14.56+0.97%$14.92$14.27288,136 shs$637.44 million04/03/2024$14.76$14.42-2.30%$14.74$13.95349,224 shs$631.31 million04/02/2024$16.19$14.76-8.83%$15.63$14.28411,126 shs$646.19 million04/01/2024$16.26$16.19-0.43%$17.49$15.78650,879 shs$708.75 million03/29/2024$16.26$16.26$16.50$15.94270,332 shs$711.86 million03/28/2024$16.50$16.26-1.45%$16.50$15.94270,332 shs$711.86 million03/27/2024$15.70$16.50+5.10%$16.53$15.32172,284 shs$722.37 million03/26/2024$15.71$15.70-0.06%$16.33$15.63183,315 shs$687.30 million03/25/2024$16.23$15.71-3.20%$16.64$15.45309,482 shs$687.78 million03/22/2024$16.94$16.23-4.19%$17.17$16.22338,785 shs$710.55 million03/21/2024$15.49$16.94+9.36%$17.26$15.74372,379 shs$741.58 million03/20/2024$14.89$15.49+4.03%$15.56$14.50288,595 shs$678.15 million03/19/2024$13.76$14.89+8.21%$15.86$13.76740,211 shs$651.88 million03/18/2024$14.70$13.76-6.39%$14.74$13.71357,821 shs$602.41 million03/15/2024$15.00$14.70-2.00%$15.23$14.58452,497 shs$643.57 million03/14/2024$15.84$15.00-5.30%$15.46$14.41308,164 shs$656.70 million03/13/2024$16.09$15.84-1.55%$16.33$15.70190,254 shs$693.48 million03/12/2024$16.49$16.09-2.43%$16.96$16.01188,388 shs$704.37 million03/11/2024$17.62$16.49-6.41%$17.39$15.39325,824 shs$721.93 million03/08/2024$17.64$17.62-0.11%$18.11$17.11211,285 shs$771.40 million03/07/2024$17.99$17.64-1.95%$18.17$17.45142,077 shs$772.23 million03/06/2024$16.64$17.99+8.11%$18.19$17.12340,923 shs$787.60 million03/05/2024$17.33$16.64-3.98%$17.29$16.34298,231 shs$728.50 million03/04/2024$18.69$17.33-7.28%$19.12$17.32460,853 shs$758.71 millionProtect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.03/01/2024$16.70$18.69+11.92%$20.90$18.251.26 million shs$815.26 million02/29/2024$16.33$16.70+2.27%$17.03$16.44320,276 shs$728.45 million02/28/2024$16.50$16.33-1.03%$16.64$15.99251,663 shs$712.32 million02/27/2024$16.50$16.50$16.89$16.26260,343 shs$719.76 million02/26/2024$16.51$16.50-0.06%$17.03$16.24209,397 shs$719.73 million02/23/2024$17.01$16.51-2.94%$17.26$16.36300,433 shs$720.17 million02/22/2024$16.47$17.01+3.28%$17.06$16.40326,753 shs$742.01 million02/21/2024$16.55$16.47-0.48%$16.65$16.03481,146 shs$718.42 million02/20/2024$16.29$16.55+1.60%$17.27$16.25438,009 shs$721.91 million02/19/2024$16.29$16.29$16.53$15.03459,200 shs$710.57 million02/16/2024$16.00$16.29+1.81%$16.53$15.03459,217 shs$710.57 million02/15/2024$15.20$16.00+5.26%$16.13$15.07383,169 shs$697.92 million02/14/2024$14.88$15.20+2.15%$16.36$14.42526,682 shs$663.02 million02/13/2024$14.36$14.88+3.62%$15.00$13.48879,348 shs$649.07 million02/12/2024$13.11$14.36+9.53%$14.49$12.97823,328 shs$626.41 million02/09/2024$12.97$13.11+1.08%$13.30$12.77293,336 shs$571.86 million02/08/2024$13.05$12.97-0.61%$13.19$11.70442,955 shs$565.75 million02/07/2024$13.59$13.05-3.97%$13.74$13.01552,974 shs$569.24 million02/06/2024$13.67$13.59-0.59%$13.81$13.28616,568 shs$592.80 million02/05/2024$14.00$13.67-2.36%$13.90$12.93474,339 shs$596.29 million02/02/2024$13.39$14.00+4.56%$14.07$13.00353,111 shs$610.68 million02/01/2024$12.79$13.39+4.69%$13.39$12.80480,152 shs$584.07 million01/31/2024$12.54$12.79+1.99%$13.39$11.81397,692 shs$557.90 million01/30/2024$12.11$12.54+3.55%$12.75$11.81498,294 shs$547.00 million01/29/2024$11.27$12.11+7.45%$12.24$10.86541,154 shs$528.26 million01/26/2024$10.54$11.27+6.93%$11.35$10.17754,315 shs$491.60 million01/25/2024$9.49$10.54+11.06%$10.59$9.38355,700 shs$459.76 million Related Companies: BCYC Stock Chart AVTE Stock Chart LBPH Stock Chart PHAR Stock Chart PRTC Stock Chart ORIC Stock Chart SLN Stock Chart SIGA Stock Chart PRAX Stock Chart ZYME Stock Chart Receive YMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YMAB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Y-mAbs Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.